Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
193.47
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AbbVie
< Previous
1
2
3
4
5
6
7
8
9
...
60
61
Next >
Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
September 20, 2024
KarXT, a novel schizophrenia drug, is on the verge of FDA approval, promising to revolutionize treatment. However, access challenges within the US healthcare system could limit its impact on mental...
Via
Benzinga
Exposures
Product Safety
Spotlight on AbbVie: Analyzing the Surge in Options Activity
September 20, 2024
Via
Benzinga
Competitor Analysis: Evaluating AbbVie And Competitors In Biotechnology Industry
September 19, 2024
Via
Benzinga
2024 Election: Drug Prices Remain A 'Hot Topic.' Can Pharma Stocks Withstand The Pressure?
September 19, 2024
Pharma stock have been on the rise in the latter half of the year, but the 2024 election remains a wild card for shares.
Via
Investor's Business Daily
2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again
September 19, 2024
For over a decade, these two drugmakers consistently outperformed the benchmark index and could do it again.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Is ABBVIE INC Ready to Break Out of Its Range?
September 17, 2024
Interesting Technical Analysis finding for ABBVIE INC (NYSE:ABBV)
Via
Chartmill
What the Options Market Tells Us About AbbVie
September 11, 2024
Via
Benzinga
Spotlight on AbbVie: Analyzing the Surge in Options Activity
September 09, 2024
Via
Benzinga
Peering Into AbbVie's Recent Short Interest
September 06, 2024
Via
Benzinga
Abbie Inc Stocks Elliott Wave Technical Analysis - Wednesday, September 18,
September 18, 2024
Looking for upside into wave {v} as we are trading within the parallel channel where we could eventually seek for support within wave {iv}.
Via
Talk Markets
TransDigm, BJ's Wholesale, AbbVie And More On CNBC's 'Final Trades'
September 17, 2024
TransDigm Group (TDG), BJ's Wholesale (BJ), VanEck Semiconductor ETF (SMH), and AbbVie (ABBV) were recommended as top trades on CNBC's Halftime Report.
Via
Benzinga
Topics
ETFs
Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
September 16, 2024
The dividend growth powerhouse is turning the corner.
Via
The Motley Fool
Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More
September 14, 2024
Financial factors aren't the only things that are worth paying attention to.
Via
The Motley Fool
3 Stocks to Buy and Hold Forever
September 14, 2024
These stocks are built for the long run.
Via
The Motley Fool
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
September 14, 2024
Their dividends are solid. And their businesses are built for the long run.
Via
The Motley Fool
Here's How Much $100 Invested In AbbVie 10 Years Ago Would Be Worth Today
September 05, 2024
Via
Benzinga
Time To Invest And Or Trade In Bio-Tech Stocks?
September 13, 2024
Biotechnology stocks and biotech exchange-traded funds ETFs once played a significant role in growth equity rallies, but today it seems like those days are in the past. Will an interest rate cut help...
Via
Talk Markets
Topics
ETFs
Is This Company Still a Strong Buy After Tripling the S&P 500's Returns?
September 13, 2024
The stock has been a winner, but there may be better times ahead for buying.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
UnitedHealth Follows Competitors, Replaces Humira with Lower-Cost Biosimilars
September 11, 2024
UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs.
Via
Benzinga
Teva Announces $80M Settlement To Baltimore: City Continues Opioid Litigation Against Other Companies
September 10, 2024
Baltimore secures an $80 million settlement with Teva Pharmaceuticals in its opioid crisis litigation. Funds will be allocated to education, recovery centers, and outreach initiatives.
Via
Benzinga
3 Things You Need to Know if You Buy AbbVie Stock Today
September 09, 2024
This dynamic big pharma is undergoing a few key changes.
Via
The Motley Fool
3 No-Brainer Dividend Stocks to Buy in September
September 08, 2024
These stocks pay great dividends and could be long-term winners.
Via
The Motley Fool
Earn $1,000 Per Month in Dividends From These 4 Stocks
September 07, 2024
A mix of various types of dividend investments.
Via
The Motley Fool
Psychedelic Drugs Market Set To Grow By $1.37B By 2028, Driven By Mental Health Disorders And AI Integration
September 05, 2024
The global psychedelic drugs market is projected to grow by USD 1.37 billion by 2028, driven by mental health needs and AI advancements in drug development.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Got $1,000? 3 Healthcare Stocks to Buy and Hold Forever
September 05, 2024
There is something for everybody in America's $4.5 trillion healthcare market.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 03, 2024
Via
Benzinga
2 Dividend Stocks You Can Safely Hold Through a Recession
September 02, 2024
These stocks can help you sleep peacefully at night, even in bad times.
Via
The Motley Fool
2 High-Yield Dividend Stocks to Buy in September and Hold for a Decade or Longer
September 01, 2024
A drugmaker and a telecom business have what it takes to safely boost your passive income stream.
Via
The Motley Fool
Stock Market Rally Mixed; Dow Jones Hits High While Nvidia Tumbles On Earnings: Weekly Review
August 30, 2024
The Dow Jones hit a new high while Nvidia led a Nasdaq retreat.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
2 Monster Stocks You Can Buy Right Now Before They Surge Even Higher
August 30, 2024
These businesses can stand the test of time in a diversified portfolio.
Via
The Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
60
61
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.